Parameter

Category

N

Mortality: n (%)

In-Hospital N = 19

Follow-Up N = 90

p-value

Gender

Females

153

6 (3.9)

38 (24.8)

0.390

Males

190

13 (6.8)

52 (27.4)

Age group, years

<50

47

0 (0)

1 (2.1)

<0.001

50 - 69

141

7 (5)

22 (15.6)

>70

155

12 (7.7)

67 (43.2)

CAD

Yes

85

8 (9.4)

27 (31.8)

0.054

No

258

11 (4.3)

63 (24.4)

CAD with revascularization history

CAD-no CABG-PCI

44

5 (11.4)

22 (50)

<0.001

CAD-CABG

21

2 (9.5)

3 (14.3)

CAD-PCI

20

1 (5)

2 (10)

No CAD

258

11 (4.3)

63 (24.4)

Hypertension

Yes

247

16 (6.5)

68 (27.5)

0.272

No

96

3 (3.1)

22 (22.9)

Diabetes

Yes

99

3 (3)

30 (30.3)

0.286

No

244

16 (6.6)

60 (24.6)

Dyslipidemia

Yes

196

10 (5.1)

56 (28.6)

0.510

No

147

9 (6.1)

34 (23.1)

Peripheral vascular disease

Yes

202

17 (8.4)

64 (31.7)

<0.001

No

141

2 (1.4)

26 (18.4)

Cr > 2.0 mg/dL or HD

Yes

17

0 (0)

12 (70.6)

<0.001

No

326

19 (5.8)

78 (23.9)

Glasgow coma scale

<9

301

2 (0.7)

77 (25.6)

<0.001

9-12

30

6 (20)

12 (40)

>12

12

11 (91.7)

1 (8.3)

Pulse pressure group (mmHg)

≥70

115

8 (7)

40 (34.8)

0.020

<70

207

9 (4.3)

46 (22.2)

IV anti-HTN Rx

Yes

49

3 (6.1)

20 (40.8)

0.037

No

294

16 (5.4)

70 (23.8)

ACEI or ARBs

Yes

215

8 (3.7)

59 (27.4)

0.150

No

128

11 (8.6)

31 (24.2)

Beta-blockers

Yes

180

9 (5)

61 (33.9)

0.003

No

163

10 (6.1)

29 (17.8)

ACEI or ARB and beta-blocker group

ACEI or ARB and beta-blocker

134

6 (4.5)

46 (34.3)

0.011

ACEI or ARB without beta-blocker

81

2 (2.5)

13 (16)

Beta-blocker without ACEI or ARB

46

3 (6.5)

15 (32.6)

No ACEI or ARB or beta-blocker

82

8 (9.8)

16 (19.5)

Diuretics

Yes

36

2 (10.5)

7 (19.4)

0.613

No

307

17 (5.5)

83 (27)

Other anti-HTN Rx

Yes

10

0 (0)

3 (30)

0.957

No

333

19 (6.5)

87 (26.1)